Liquidia's chart data is dated 2026-10-09. There is no active technical signal. There are 5 published signal records.
Liquidia last closed at $27.38 (-2.28%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is 20.5×. Its overall grade ranks 263 of 738 stocks in Healthcare.
About this company
Liquidia last closed at $27.38 (-2.28%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 263/738
Valuation grade F
Related stocks
- United TherapeuticsCompetitor
폐고혈압 치료제 시장에서 Liquidia와 직접 경쟁하는 주요 기업
- YutrepiaRelated theme
Liquidia의 핵심 파이프라인/제품으로, 투자 관점에서 핵심 사업 축
- TyvasoCompetitor
흡입형 treprostinil 계열의 대표 치료제로 Liquidia의 주력 경쟁 대상
About Liquidia
- What technical signals does Liquidia (LQDA) have?
- Liquidia current technical signals: no active technical signal.
- Is Liquidia a cup-and-handle pattern?
- No. Liquidia has no valid Cup signal right now.
- What published figures are available for Liquidia?
- Market cap: $2.38B. Trailing 12 months PER: 20.5×. Latest quarter PBR: 14.56×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Liquidia, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.